These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1283514)

  • 41. Surface activity of drugs: oximes of 3-formylrifamycin SV.
    Pelizza G; Allievi GC; Gallo GG
    Farmaco Sci; 1976 Jan; 31(1):31-40. PubMed ID: 939317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-vitro inhibition of RNA-instructed DNA polymerase.
    Rainer H; Lutz D; Stacher A; Deutsch E; Moser K
    Arzneimittelforschung; 1975 May; 25(5):735-7. PubMed ID: 52362
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The retroviral enzymes.
    Katz RA; Skalka AM
    Annu Rev Biochem; 1994; 63():133-73. PubMed ID: 7526778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dimeric hydrazones of 3-formylrifamycin SV:synthesis, antibacterial activity and other biological properties.
    Cricchio R
    Farmaco Sci; 1976 Nov; 31(11):791-6. PubMed ID: 1010030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydrazones of 3-formylrifamycin SV. III - N(mono and di)substituted hydrazone derivatives: synthesis, antibacterial activity and other biological properties.
    Cricchio R; Carniti G; Cietto G; Tamborini G; Arioli V
    Farmaco Sci; 1975 Sep; 30(9):704-20. PubMed ID: 1157919
    [No Abstract]   [Full Text] [Related]  

  • 46. Detergent effects on a reverse transcriptase activity and on inhibition by rifamycin derivatives.
    Thompson FM; Libertini LJ; Joss UR; Calvin M
    Science; 1972 Nov; 178(4060):505-7. PubMed ID: 4116919
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of mutagenesis induced by expression of retroviral reverse transcriptase in Escherichia coli.
    Ennis DG; Crouch RJ
    Biochimie; 1993; 75(1-2):101-5. PubMed ID: 7684931
    [TBL] [Abstract][Full Text] [Related]  

  • 48. M-MuLV reverse transcriptase: Selected properties and improved mutants.
    Oscorbin IP; Filipenko ML
    Comput Struct Biotechnol J; 2021; 19():6315-6327. PubMed ID: 34900141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interruption of oncornavirus replication by modified rifamycin antibiotics.
    O'Connor TE
    Ann N Y Acad Sci; 1977 Mar; 284():544-65. PubMed ID: 81643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rifamycin derivatives as inhibitors of a ribonucleic acid instructed deoxyribonucleic acid polymerase function. Effect of lipophilicity.
    Tischler AN; Thomspon FM; Libertini LJ; Calvin M
    J Med Chem; 1974 Sep; 17(9):948-52. PubMed ID: 4370348
    [No Abstract]   [Full Text] [Related]  

  • 51. Rational chemotherapy: inhibition of polymerase activity of cancer cells.
    Knock FE; Galt RM; Oester YT; Sylvester R
    JAMA; 1973 Apr; 224(1):129. PubMed ID: 4120334
    [No Abstract]   [Full Text] [Related]  

  • 52. Diaryl amidine derivatives as oncornaviral DNA polymerase inhibitors.
    Clercq ED; Dann O
    J Med Chem; 1980 Jul; 23(7):787-95. PubMed ID: 6157024
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of murine leukemia virus with poly-2'-O-(2,4-dinitrophenyl)poly[A].
    Ashun MA; Hu Y; Kang I; Li CC; Wang JH
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2311-7. PubMed ID: 8891136
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New rifamycins modified at positions 3 and 4. Synthesis, structure and biological evaluation.
    Marsili L; Pasqualucci CR; Vigevani A; Gioia B; Schioppacassi G; Oronzo G
    J Antibiot (Tokyo); 1981 Aug; 34(8):1033-8. PubMed ID: 7319919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depression of reverse transcriptase activity by hybridoma supernatants: a potential problem in screening for retroviral contamination.
    Lyon M; Huppert J
    Biochem Biophys Res Commun; 1983 Apr; 112(1):265-72. PubMed ID: 6188467
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel rifamycins. IV. 3-Aminomethylazinomethylrifamycins, a new class of rifamycins, endowed with remarkable antibacterial activity.
    Marsili L; Franceschi G; Ballabio M; Vioglio S; Vigevani A; Ungheri D; Della Bruna C; Sanfilippo A
    J Antibiot (Tokyo); 1984 Oct; 37(10):1209-12. PubMed ID: 6501091
    [No Abstract]   [Full Text] [Related]  

  • 57. Conformational variety for the ansa chain of rifamycins: comparison of observed crystal structures and molecular dynamics simulations.
    Bacchi A; Pelizzi G
    J Comput Aided Mol Des; 1999 Jul; 13(4):385-96. PubMed ID: 10425603
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rifamycins: modulation of specific anti-poxviral activity by small substitutions on the piperazinyliminomethyl side chain.
    Moss B; Rosenblum EN; Grimley PM; Mims SJ
    Antimicrob Agents Chemother; 1972 Sep; 2(3):181-5. PubMed ID: 4790556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antireverse transcriptase activity of gliotoxin analogs.
    De Clercq E; Billiau A; Ottenheijm HC; Herscheid JD
    Biochem Pharmacol; 1978 Mar; 27(5):635-9. PubMed ID: 77666
    [No Abstract]   [Full Text] [Related]  

  • 60. Unusual rearrangement of 3-hydrazino-rifamycins leading to the enlargement of the "natural" ansa bridge.
    Marsili L; Ballabio M; Franceschi G; Oronzo G; Vigevani A
    J Antibiot (Tokyo); 1982 Nov; 35(11):1621-3. PubMed ID: 7161200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.